Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	10	13	20	20	24	30
Market Cap Growth	-37.45%	-31.76%	-1.11%	-16.81%	-20.06%	47.47%
Enterprise Value	-2	1	5	6	8	16
Last Close Price	0.43	0.51	0.69	0.65	0.66	0.79
PE Ratio	-	-	14.89	19.60	-	14.47
Forward PE	3.91	11.50	11.50	13.23	12.12	8.90
PS Ratio	1.03	1.40	1.15	1.02	1.18	1.38
PB Ratio	0.82	0.97	1.21	1.19	1.25	1.31
P/TBV Ratio	0.82	0.97	1.21	1.19	1.25	1.31
P/FCF Ratio	-	-	10.36	34.42	29.87	20.34
P/OCF Ratio	-	-	10.32	33.31	29.47	19.59
EV/Sales Ratio	-	0.07	0.31	0.31	0.39	0.73
EV/EBITDA Ratio	-	-	4.56	4.91	-	6.78
EV/EBIT Ratio	-	-	4.75	5.12	-	7.05
EV/FCF Ratio	1.28	-	2.82	10.49	9.97	10.75
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.03	0.12
Debt / EBITDA Ratio	-	-	0.26	0.35	-	1.09
Debt / FCF Ratio	-	-	0.18	0.85	0.78	1.87
Asset Turnover	0.54	0.53	0.84	0.87	0.75	0.76
Quick Ratio	4.42	8.08	8.78	9.23	8.27	7.08
Current Ratio	4.54	8.32	9.01	9.46	8.55	7.54
Return on Equity (ROE)	-3.81%	-5.21%	8.02%	5.68%	-10.04%	9.47%
Return on Assets (ROA)	-3.33%	-4.45%	3.44%	3.29%	-8.95%	4.92%
Return on Capital (ROIC)	-4.42%	-5.30%	4.17%	4.01%	-10.71%	6.03%
Return on Capital Employed (ROCE)	-	-	6.30%	6.30%	-	8.50%
Earnings Yield	-5.05%	-5.84%	6.71%	5.10%	-8.81%	6.91%
FCF Yield	-19.06%	-5.46%	9.65%	2.90%	3.35%	4.92%
Payout Ratio	-	-	131.57%	342.37%	-	84.12%
Buyback Yield / Dilution	0.17%	0.10%	0.15%	0.56%	-0.53%	0.32%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.